<DOC>
	<DOC>NCT01767337</DOC>
	<brief_summary>This study will evaluate intracutaneous delivery of 0.1, 0.25 and 0.5 milliliter volumes of saline from the FLUGEN 101.2 investigational microneedle-based device.</brief_summary>
	<brief_title>Intracutaneous Delivery of Varied Dose Volumes of Saline</brief_title>
	<detailed_description />
	<criteria>Able to read and/or understand and sign the Informed Consent form Medical history of acute or chronic skin disease Active skin allergy or acute skin infection, presence of tattoo(s), scars, sunburn or skin abnormalities at any prospective injection site Hirsute at any prospective injection site Diabetes High levels of anxiety or depression or history of psychosis Abuse of alcohol or use of other drugs of abuse including tobacco Pregnant or breastfeeding women Any medical condition that may interfere with study protocol adherence including completion of study activities Foreseeable inability to complete the study as scheduled.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>microneedle-based delivery</keyword>
	<keyword>hollow microneedle</keyword>
	<keyword>intracutaneous</keyword>
	<keyword>drug delivery</keyword>
</DOC>